Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
BRIEF COMMUNICATIONS
You have accessRestricted Access

Anemia and Iron Deficiencies among Long-Term Renal Transplant Recipients

Matthias Lorenz, Josef Kletzmayr, Agnes Perschl, Alexander Furrer, Walter H. Hörl and Gere Sunder-Plassmann
JASN March 2002, 13 (3) 794-797; DOI: https://doi.org/10.1681/ASN.V133794
Matthias Lorenz
Division of Nephrology and Dialysis, Department of Medicine III, University of Vienna, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josef Kletzmayr
Division of Nephrology and Dialysis, Department of Medicine III, University of Vienna, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agnes Perschl
Division of Nephrology and Dialysis, Department of Medicine III, University of Vienna, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Furrer
Division of Nephrology and Dialysis, Department of Medicine III, University of Vienna, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter H. Hörl
Division of Nephrology and Dialysis, Department of Medicine III, University of Vienna, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gere Sunder-Plassmann
Division of Nephrology and Dialysis, Department of Medicine III, University of Vienna, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

ABSTRACT. Iron deficiency anemia after renal transplantation has not been systematically investigated. The prevalence of anemia and the indicators of iron deficiency among 438 renal transplant recipients were examined. Anemia was present in 39.7% of the patients. The prevalence of iron deficiencies, as indicated by a percentage of hypochromic red blood cells (HRBC) of ≥2.5%, was 20.1%. The majority of severely anemic patients exhibited HRBC values in the upper quartile. Positive associations of hemoglobin levels with creatinine clearance, serum transferrin levels, male gender, transferrin saturation (TSAT), polycystic kidney disease, and age were observed. Negative associations with erythropoietin therapy, use of azathioprine, serum ferritin levels, and body mass index were observed. The risk for anemia was closely related to the highest quartile of HRBC percentages (odds ratio, 2.35; 95% confidence interval, 1.48 to 3.75; P = 0.00029), whereas ferritin levels and TSAT conferred no risk for anemia. Therefore, assessment of the HRBC proportion is superior to decreased ferritin and decreased TSAT measurements for the diagnosis of iron deficiencies among renal transplant recipients.

Anemia among long-term renal transplant recipients (RTR) is not well documented (1). Even fewer data on iron status and iron deficiencies among these patients are available. In this study, we examined the prevalence of anemia and iron deficiency anemia among long-term RTR in stable condition.

Materials and Methods

All patients who visited the kidney transplant outpatient service at the University Hospital of Vienna during a period of 4 wk were included in a cross-sectional study. The patients exhibited stable graft function. Blood chemistry values were determined by using standard methods. Transferrin saturation (TSAT) was calculated as iron level/serum transferrin level × 70.9. Whole blood counts and percentages of hypochromic red blood cells (HRBC) were analyzed with a Technicon H*2 hematology analyzer (Bayer Diagnostics, Tarrytown, NY). Creatinine clearance values were calculated with the equation described by Cockcroft and Gault (2).

Independent associations with hemoglobin levels were examined in multiple stepwise regression analyses. The distribution of skewed data was normalized by natural logarithmic transformation. Logistic regression models were constructed to examine the risks (odds ratios and 95% confidence intervals) for anemia (i.e., hemoglobin levels of <12 g/dl for women and <13 g/dl for men) associated with markers of iron metabolism in the highest (HRBC) or lowest (serum ferritin levels, TSAT, serum iron levels, and serum transferrin levels) quartile of the whole patient population. To avoid multicollinearity, anemia was related to five sets of variables, in which one of five iron markers was entered. In these models, the most important predictors of hemoglobin levels (derived from the stepwise regression analyses) were also considered, i.e., creatinine clearance values below or above the median, azathioprine use (yes/no term), and polycystic kidney disease (yes/no term).

Results

The characteristics of all 438 RTR are indicated in Table 1. The proportions of patients with iron status markers within or outside the reference range are presented in Table 2. The prevalence of anemia among RTR was 39.7%. Iron deficiency was indicated by a proportion of HRBC of ≥2.5% for 88 patients (20.1%). The association of all variables with hemoglobin levels is presented in Table 3. Increased serum ferritin levels were associated with decreased hemoglobin concentrations. Serum transferrin levels were elevated in parallel with hemoglobin levels. The risks for anemia conferred by five markers of iron metabolism are presented in Figure 1. Among anemic or severely anemic patients, HRBC elevations were more frequent than hypoferritinemia or decreased TSAT values. The majority of patients with hemoglobin levels of <11 g/dl presented with HRBC values in the highest quartile (Table 4).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. Markers of iron status and risk of anemia among 438 renal transplant recipients (the worst versus the other three quartiles, by logistic regression analysis). Hypochromic red blood cells (RBC): odds ratio (OR), 2.35; 95% confidence interval (CI), 1.48 to 3.75; P = 0.00029; serum transferrin level: odds ratio, 1.96; 95% confidence interval, 1.23 to 3.11; P = 0.004395; serum iron level: odds ratio, 1.56; 95% confidence interval, 0.97 to 2.49; P = 0.063608; serum ferritin level: odds ratio, 0.73; 95% confidence interval, 0.46 to 1.18; P = 0.19989; transferrin saturation (TSAT): odds ratio, 1.02; 95% confidence interval, 0.63 to 1.63; P = 0.942653.

View this table:
  • View inline
  • View popup
Table 1.

Patient characteristicsa

View this table:
  • View inline
  • View popup
Table 2.

Indices of iron status within or out of the reference rangea

View this table:
  • View inline
  • View popup
Table 3.

Independent associations with hemoglobin levels among 438 kidney graft recipients (by multiple stepwise regression analyses)a

View this table:
  • View inline
  • View popup
Table 4.

Prevalence of iron deficiencies among anemic (hemoglobin levels of <12 g/dl for women or <13 g/dl for men) and severely anemic (hemoglobin levels of <11 g/dl) RTR, according to standard cut-off levels or worst quartiles of laboratory parameters of iron statusa

Discussion

Our study suggests that we do not attach enough importance to the diagnosis and management of anemia among RTR in stable condition. This is obviously attributable to the prevalence of unrecognized iron deficiencies, which is related to the poor information obtained from ferritin or TSAT measurements. Only 10.1% of severely anemic patients presented with serum ferritin levels of <12 μg/L, and TSAT values of <15% were observed for 29%. These results underestimate by far the number of patients with functional iron deficiencies, because HRBC values of >2.5% were detected for 46.4% and values in the upper quartile were detected for 52.2% of our severely anemic patients, reaching 64.1% among female patients. These findings strongly suggest that iron deficiencies, as diagnosed by serum ferritin or TSAT measurements, remain undetected in a significant proportion of RTR. Factors related to the prevalence of iron deficiencies may include occult blood losses, blood sampling, and adherence to a low-meat dietary regimen.

Ferritin levels may vary and may be elevated independently of iron stores in conditions such as inflammatory or infectious diseases, malignancies, or iron overload (3,4). In contrast to the negative association of serum ferritin levels with hemoglobin concentrations, C-reactive protein levels demonstrated no association with hemoglobin concentrations in our study. This finding may be attributable to immunosuppressive therapy, which was demonstrated to suppress C-reactive protein production (5). There was also a weak negative independent association of C-reactive protein with HRBC in our study population (data not shown), indicating that increases in HRBC values were not related to inflammation anemia.

In this study, a proportion of HRBC in the highest quartile substantially increased the risk for anemia, whereas decreased serum ferritin levels and decreased TSAT conferred no risk (Figure 1). Therefore, our findings support a concept in which continuous decreases in HRBC levels, even to ≤2%, may indicate gradual improvement of the iron supply (6,7).

A potential limitation of our study may be the lack of analysis of angiotensin I-converting enzyme (ACE) inhibition. The effect of ACE inhibition on hemoglobin levels is a matter of debate. However, the largest study reported to date clearly demonstrated that ACE inhibitor therapy did not decrease hemoglobin levels among RTR with normal hemoglobin levels (8). Another point of concern may be the lack of bone marrow examinations as the standard iron supply test. However, invasive studies are not reasonable for a large patient population.

In summary, we demonstrate that (1) anemia and iron deficiencies are under-recognized among RTR in stable condition, (2) the proportion of HRBC is the most important indicator of iron deficiencies among RTR, and (3) measurements of serum ferritin levels and TSAT are not always sufficient for the diagnosis of iron deficiencies among RTR. References.

  • © 2002 American Society of Nephrology

References

  1. ↵
    Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, Roth D, Scandling JD, Singer GG: Recommendations for the outpatient surveillance of renal transplant recipients: American Society of Transplantation. J Am Soc Nephrol 11 [Suppl 15]: S1–S86, 2000
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31–41, 1976
    OpenUrlCrossRefPubMed
  3. ↵
    Kaltwasser JP, Gottschalk R: Erythropoietin and iron. Kidney Int 55 [Suppl 69]: S49–S56, 1999
    OpenUrlCrossRef
  4. ↵
    Miles AMV, Markell MS, Daskalakis P, Sumrani NB, Hong J, Sommer BG, Friedman EA: Anemia following renal transplantation: Erythropoietin response and iron deficiency. Clin Transplant 11: 313–315, 1997
    OpenUrlPubMed
  5. ↵
    Van Lente F, Castellani W, Abbott LB: Changes in concentrations of C-reactive protein in serum after kidney or heart transplantation. Clin Chem 32: 633–636, 1986
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Macdougall IC, Cavill I, Hulme B, Bain B, McGregor E, McKay P, Sanders E, Coles GA, Williams JD: Detection of functional iron deficiency during erythropoietin treatment: A new approach. Br Med J 304: 225–226, 1992
    OpenUrlFREE Full Text
  7. ↵
    Braun J, Lindner K, Schreiber M, Heidler RA, Hörl WH: Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients. Nephrol Dial Transplant 12: 1173–1181, 1997
    OpenUrlCrossRefPubMed
  8. ↵
    Stigant CE, Cohen J, Vivera M, Zaltzman JS: ACE inhibitors and angiotensin II antagonists in renal transplantation: An analysis of safety and efficacy. Am J Kidney Dis 35: 58–63, 2000
    OpenUrlPubMed
  9. National Kidney Foundation–Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) Work Group: NKF-K/DOQI clinical practice guidelines for anemia of chronic kidney disease: Update 2000. Am J Kidney Dis 37 [suppl 1]: S182–S238, 2001
    OpenUrlCrossRefPubMed
  10. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL: Prevalence of iron deficiency in the United States. JAMA 277: 973–976, 1997
    OpenUrlCrossRefPubMed
  11. Jordan CD, Flood JG, Laposata M, Lewandrowski KB: Case records of the Massachusetts General Hospital: Weekly clinicopathological exercises: Normal reference laboratory values. Engl J Med 327: 718–724, 1992
    OpenUrlCrossRefPubMed
  12. Sham RL, Raubertas RF, Braggins C, Cappuccio J, Gallagher M, Phatak PD: Asymptomatic hemochromatosis subjects: Genotypic and phenotypic profiles. Blood 96: 3707–3711, 2000
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 13 (3)
Journal of the American Society of Nephrology
Vol. 13, Issue 3
1 Mar 2002
  • Table of Contents
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Anemia and Iron Deficiencies among Long-Term Renal Transplant Recipients
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Anemia and Iron Deficiencies among Long-Term Renal Transplant Recipients
Matthias Lorenz, Josef Kletzmayr, Agnes Perschl, Alexander Furrer, Walter H. Hörl, Gere Sunder-Plassmann
JASN Mar 2002, 13 (3) 794-797; DOI: 10.1681/ASN.V133794

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Anemia and Iron Deficiencies among Long-Term Renal Transplant Recipients
Matthias Lorenz, Josef Kletzmayr, Agnes Perschl, Alexander Furrer, Walter H. Hörl, Gere Sunder-Plassmann
JASN Mar 2002, 13 (3) 794-797; DOI: 10.1681/ASN.V133794
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Serum Response Factor Is Essential for Maintenance of Podocyte Structure and Function
  • Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy
  • TRPC5 Does Not Cause or Aggravate Glomerular Disease
Show more BRIEF COMMUNICATIONS

Cited By...

  • C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients
  • Human Cytomegalovirus Inhibits Erythropoietin Production
  • Serum Erythropoietin Level and Mortality in Kidney Transplant Recipients
  • Posttransplantation Anemia: Mechanisms and Management
  • Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study
  • Pottransplantation Anemia: Management and Rationale
  • Clinical Aspects of Iron Use in the Anemia of Kidney Disease
  • Pharmacoepidemiology of Anemia in Kidney Transplant Recipients
  • Iron Status and Hemoglobin Level in Chronic Renal Insufficiency
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2022 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire